Home Dialysis in the Prospective Payment System Era
- PMID: 28490435
- PMCID: PMC5619970
- DOI: 10.1681/ASN.2017010041
Home Dialysis in the Prospective Payment System Era
Abstract
The ESRD Prospective Payment System introduced two incentives to increase home dialysis use: bundling injectable medications into a single payment for treatment and paying for home dialysis training. We evaluated the effects of the ESRD Prospective Payment System on home dialysis use by patients starting dialysis in the United States from January 1, 2006 to August 31, 2013. We analyzed data on dialysis modality, insurance type, and comorbidities from the United States Renal Data System. We estimated the effect of the policy on home dialysis use with multivariable logistic regression and compared the effect on Medicare Parts A/B beneficiaries with the effect on patients with other types of insurance. The ESRD Prospective Payment System associated with a 5.0% (95% confidence interval [95% CI], 4.0% to 6.0%) increase in home dialysis use by the end of the study period. Home dialysis use increased by 5.8% (95% CI, 4.3% to 6.9%) among Medicare beneficiaries and 4.1% (95% CI, 2.3% to 5.4%) among patients covered by other forms of health insurance. The difference between these groups was not statistically significant (1.8%; 95% CI, -0.2% to 3.8%). Conversely, in both populations, the training add-on did not associate with increases in home dialysis use beyond the effect of the policy. The ESRD Prospective Payment System bundling, but not the training add-on, associated with substantial increases in home dialysis, which were identical for both Medicare and non-Medicare patients. These spill-over effects suggest that major payment changes in Medicare can affect all patients with ESRD.
Keywords: Economic Analysis; United States Renal Data System; chronic dialysis; end-stage renal disease; peritoneal dialysis.
Copyright © 2017 by the American Society of Nephrology.
Figures
References
-
- United States Renal Data System : Medicare expenditures for persons with ESRD. In: 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2016
-
- Burkart J: The future of peritoneal dialysis in the United States: Optimizing its use. Clin J Am Soc Nephrol 4[Suppl 1]: S125–S131, 2009. - PubMed
-
- Klarenbach S, Manns B: Economic evaluation of dialysis therapies. Semin Nephrol 29: 524–532, 2009 - PubMed
-
- Hornberger J, Hirth RA: Financial implications of choice of dialysis type of the revised Medicare payment system: An economic analysis. Am J Kidney Dis 60: 280–287, 2012 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
